Prospective Cohort With Hemopathy in Languedoc-Roussillon

Prospective Cohort Study of Clinical and Laboratory Data of Patients With Hemopathy in Languedoc-Roussillon

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02134574

Acronym

HemoDiag

Enrollment

500

Registered

2014-05-09

Start date

2014-02-01

Completion date

2033-06-01

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Malignancy

Keywords

Lymphoma,, leukemia,, multiple myeloma,, hodgkin disease

Brief summary

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.

Detailed description

Prospective Cohort Study of clinical and laboratory data of patients with hemopathy in LR.

Interventions

BIOLOGICALhematologic malignancy

hematologic malignancy with a sampling of blood

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age over 18 * Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent * Having signed an informed consent * Affiliated with a social security scheme

Exclusion criteria

* Minor or major protected * Patients who have received treatment for hematological pathology

Design outcomes

Primary

Measure	Time frame	Description
Survival with 2 years	2 years	Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC\_QLQ-C30

Secondary

Measure	Time frame	Description
Survival with 5 years	5 years	Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC\_QLQ-C30
Survival with 10 years	10 years	Prospective Cohort Study of clinical and biological data Analysis Biological, clinical and questionnaire EORTC\_QLQ-C30

Countries

France

Contacts

CONTACTValerie ROUILLE

v-rouille@chu-montpellier.fr

PRINCIPAL_INVESTIGATORGUILLAUME CARTRON

University Hospital, Montpellier

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026